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Abstract: Background: Data are limited regarding the association of cumulative burden and trajectory
of body mass index (BMI) from early life with adult lipid disorders. Methods: The study cohort
consisted of 5195 adults who had BMI repeatedly measured 4 to 21 times from childhood and had
blood lipid measurements of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein
cholesterol (HDL-C), and triglycerides (TG) and information on lipid-lowering medications in the last
adult survey. The area under the curve (AUC) was calculated as a measure of long-term burden (total
AUC) and trends (incremental AUC) of BMI. Results: Participants with dyslipidemia, high LDL-C,
low HDL-C and high TG had consistently and significantly higher BMI levels from childhood to
adulthood compared to those with normal lipid levels. After adjusting for age, race, sex, and cohort,
increased risk of adult dyslipidemia was significantly associated with higher values of childhood
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BMI, adulthood BMI, total AUC and incremental AUC, with odds ratio (95% confidence interval)
= 1.22 (1.15–1.29), 1.85 (1.74–1.97), 1.61 (1.52–1.71), and 1.59 (1.50–1.69), respectively, and p < 0.001
for all. The association patterns were similar in most race–sex subgroups. Conclusions: Adults
with dyslipidemia versus normal lipid levels have consistently higher levels and distinct life-course
trajectories of BMI, suggesting that the impact of excessive body weight on dyslipidemia originates in
early life.
Keywords: body mass index; dyslipidemia; longitudinal study; childhood
1. Introduction
Dyslipidemia has been a major public health problem [1,2]. Clinical and epidemiologic studies
have demonstrated that lipid disorders are associated with insulin resistance and predict increased
risk of cardiovascular mortality and morbidity [3]. Obesity is a pandemic of the modern world [4],
and is intimately associated with dyslipidemia for both youth and adults [5–7]. Many longitudinal
cohorts followed since childhood have shown that early-life body mass index (BMI) is associated with
an adult adverse lipid profile [8–12]. Data, however, are limited regarding the influence of long-term
cumulative burden of excessive body weight from childhood on adult dyslipidemia.
BMI changes dramatically with age but tends to track in the same ranking over time. Higher
BMI in childhood strongly predicts increased risk of adult obesity, suggesting that adult obesity
originates in early life [13,14]. Nonlinear growth trajectories of BMI from childhood to midlife have
been characterized in the Bogalusa Heart Study cohort [15]. During the past couple of decades,
a statistical methodology, group-based trajectory modeling, has been increasingly applied to map the
developmental course of changes with age in cardiovascular risk factors. Life-long follow-up cohort
studies have demonstrated that trajectory group membership of longitudinal BMI growth during
different age periods is associated with cardiovascular disease and cardiometabolic risk, including
lipid disorders [16–19].
In previous studies using the group-based trajectory model [16–19], the membership of distinct
groups was used as a risk factor variable to assess its association with outcomes. Individual-level
trajectory parameters of longitudinal changes in BMI would provide detailed information on the
patterns of change in body weight in a particular age period from early life in relation to subsequent
health outcomes. However, no studies have examined whether adults with and without dyslipidemia
have distinct life-course BMI trajectories from childhood. Utilizing pooled data from the International
Childhood Cardiovascular Cohort (i3C) Consortium, we aimed to characterize the individual-specific
life-course growth trajectories and cumulative burden of BMI from childhood to adulthood and
examine their associations with adult dyslipidemia.
2. Materials and Methods
2.1. Study Cohort
Detailed descriptions for the i3C Consortium have been published elsewhere [20,21]. In brief,
the i3C Consortium included seven longitudinal cohort studies initiated in childhood from the US,
Finland and Australia. In this study, we included participants from the i3C Consortium who were
examined for weight and height at least 2 times in childhood (3–19 years) and at least 2 times in
adulthood (20–52 years) and had blood lipid measurements of low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG), and information on
lipid-lowering medications in the last adult survey. According to these inclusion criteria, the final
study cohort consisted of 5195 participants from five of the seven cohorts, i.e., the Bogalusa Heart
Study (BHS), the Muscatine Study (MUSC), the National Heart, Lung and Blood Institute Growth and
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Health Study (NGHS) and the Prevention of High Blood Pressure in Children Study (PHBPC) in the
US, and the Cardiovascular Risk in Young Finns Study (YFS) in Finland. Detailed descriptions of these
cohorts are provided in the Supplementary Materials. The average number of repeated measurements
for weight and height from childhood to adulthood was 8.8 (range = 4–21).
All participants or their legal guardians at each examination provided written informed consent.
The study protocols were approved by the respective Institutional Review Boards.
2.2. Examinations
Detailed study characteristics and examination methods for the five cohorts have been previously
described [20–25]. According to the Third Report of the National Cholesterol Education Program Expert
Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults [1], high LDL-C,
low HDL-C and high TG were defined as ≥160 mg/dL, ≤40 mg/dL, ≥200 mg/dL, respectively, or taking
lipid-lowering medications. Dyslipidemia was defined as the presence of any of high LDL-C, low
HDL-C and high TG. There were 235 adult participants (4.5%) who took lipid-lowering medications.
2.3. Statistical Methods
Parameters of nonlinear growth curves of BMI from childhood to adulthood were estimated
using a random-effects mixed model by SAS proc MIXED, as previously reported [26,27]. The mixed
model incorporates fixed and random effects and allows the intercept, linear and nonlinear parameters
to vary from individual to individual. The random effect coefficients represent deviations of BMI
for individuals from the fixed-effect parameters. In addition, the mixed model allows for repeated
measurements and different numbers of unequally spaced observations across individuals. The model
computes maximum-likelihood estimates of growth curve parameters, including fixed-effect parameters
(for a group) and random-effect parameters (individual specific). By combining these two types of
parameters, 5195 sets of growth curve parameters were generated for each of 5195 participants of the
study cohort. The model selection was based on the Akaike’s information criterion (AIC) and p-values
of the independent variable (age) at the significance level of 0.05. Age and its higher-order terms were
included one by one for model building. The higher-order terms of age were not included in the
model if they were not significant, or made lower-order terms not significant, or did not improve the
goodness-of-fit of the model based on AIC values. Cubic curves were fitted for BMI in race–sex groups:
BMIi = (β0 + b0i) + (β1 + b1i) age + (β2 + b2i) age
2 + (β3 + b3i) age
3 + ε
where β = (β0, β1, β2, β3)’ is a vector of fixed-effect parameters, b = (b0, b1, b2, b3)’ is a vector of
random-effect parameters, and ε is an unknown error term. Age was centered to the mean age
(22.1 years) to reduce the collinearity of age with its higher-order terms. The term age2 was divided by
10 and age3 by 20 to improve model fitting.
Long-term burden and trends of BMI were measured as the area under the curve (AUC). As shown
in Supplemental Figure S1, the AUC was calculated as the integral of the curve parameters during the
follow-up period for each participant. Because participants had different follow-up periods, the AUC
values were divided by the number of follow-up years and used for the subsequent association
analyses. Total AUC can be considered a measure of a long-term cumulative burden; incremental
AUC, determined by within-subject variations, represents a combination of linear and nonlinear
longitudinal trends.
Multivariable logistic regression analyses were performed to examine the association of
dyslipidemia with childhood values (the first survey), adulthood values (the last survey), total
and incremental AUC values of BMI, adjusted for adult age, race, sex and cohort. Four dichotomous
dummy variables were created for the five cohorts. Prior to the regression analysis, childhood and
AUC values of BMI were adjusted for childhood age and average age, respectively, using regression
residual analyses in race–sex groups by cohort and then standardized by Z-transformation (mean = 0,
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SD = 1). In addition, for regression residual analyses of incremental AUC, baseline values of childhood
BMI were included in the models for adjustment to control the regression-to-the-mean bias.
To examine whether there is an independent effect of childhood BMI on adult lipid disorders,
the risk of dyslipidemia was examined in logistic regression models in four groups divided by the
combination of low and high BMI in childhood/adulthood (low/low, high/low, low/high and high/high)
using the low/low group as reference. Low and high BMI was defined by its race-, sex- and age-specific
medians in childhood and 25.0 kg/m2 in adulthood as cut-offs. In addition, we also constructed BMI
burden using all BMI values before the last adult BMI and linked the BMI burden to adult dyslipidemia
by including the last adult BMI as a fixed effect in the association analysis models.
3. Results
The characteristics of study participants in total and five cohorts are shown in Table 1. The current
study included 5195 participants, including 4212 (80.1%) whites and 2069 (39.8%) males, with mean
(±SD) ages of 10.1 ± 3.2 years in the first childhood survey and 37.7 ± 7.2 years in the last adult
survey. The mean length of follow-up was 27.3 ± 7.0 years. The prevalence of dyslipidemia in the
total cohort was 36.9%, with BHS having the highest prevalence (45.7%) and NGHS having the lowest
prevalence (22.8%). The prevalence of high LDL-C, low HDL-C and high TG in the total cohort was
14.9%, 26.1% and 13.8%, respectively. The overall prevalence of combined overweight and obesity was
31.5% and 30.8%, respectively. The comparison of study variables between the included and excluded
participants and the characteristics of the study cohorts by race and sex are shown in Supplemental
Tables S1 and S2, respectively.
Table 1. Characteristics of study participants.
Variable BHS(n = 1739)
YFS
(n = 1718)
MUSC
(n = 776)
NGHS
(n = 575)
PHBPC
(n = 387)
Total
(n = 5195)
Male, n (%) 765 (44.0) 765 (44.5) 350 (45.1) 0 (0.0) 189 (48.8) 2069 (39.8)
White, n (%) 1181 (67.9) 1718(100.0) 776 (100.0) 258 (44.9) 279 (72.1) 4212 (80.1)
Childhood (Fist exam)
Age (year) 10.2 (3.1) 9.7 (4.1) 12.0 (2.2) 10.0 (0.5) 7.7 (0.7) 10.1 (3.2)
BMI (kg/m2) 17.8 (3.5) 17.2 (2.6) 19.0 (3.2) 18.3 (3.6) 16.5 (2.2) 17.7 (3.2)
Adulthood (Last exam)
Age (year) 38.5 (7.1) 39.5 (4.4) 39.9 (8.7) 26.2 (0.9) 39.1 (1.9) 37.7 (7.2)
BMI (kg/m2) 29.4 (7.6) 26.2 (4.7) 27.8 (6.1) 28.4 (7.9) 29.2 (6.9) 28.0 (6.7)
Overweight, n (%) a 526 (30.3) 621 (36.2) 235 (30.3) 134 (23.3) 118 (30.5) 1634 (31.5)
Obesity, n (%) b 673 (38.7) 326 (19.0) 251 (32.4) 200 (34.8) 150 (38.8) 1600 (30.8)
LDL-C (mg/dL) 126.1 (33.4) 124.8 (31.6) 117.5 (33.1) 101.4 (30.7) 111.5 (29.2) 120.6 (33.2)
HDL-C (mg/dL) 48.3 (14.6) 50.8 (12.3) 49.8 (14.4) 51.5 (13.2) 50.4 (13.8) 49.9 (13.7)
TG (mg/dL) 131.1 (96.0) 110.7 (57.3) 110.5 (66.0) 95.6 (51.0) 116.2 (65.8) 116.2 (74.6)
High LDL-C, n (%) 343 (19.7) 251 (14.6) 122 (15.7) 26 (4.5) 34 (8.8) 776 (14.9)
Low HDL-C, n (%) 568 (32.7) 357 (20.8) 232 (29.9) 102 (17.7) 96 (24.8) 1355 (26.1)
High TG, n (%) 337 (19.4) 179 (10.4) 123 (15.9) 26 (4.5) 54 (14.0) 719 (13.8)
Dyslipidemia, n (%) 794 (45.7) 569 (33.1) 300 (38.7) 132 (22.8) 121 (31.3) 1916 (36.9)
AUC measures
Average age (year) 22.5 (4.4) 23.4 (4.4) 26.4 (6.3) 17.6 (0.8) 14.9 (0.7) 22.3 (5.3)
BMI AUCt (kg/m2) 24.7 (5.1) 22.7 (3.3) 24.5 (4.2) 24.5 (5.5) 24.7 (4.7) 24.0 (4.6)
BMI AUCi (kg/m2) 6.9 (3.9) 5.6 (2.3) 5.3 (3.1) 5.9 (3.2) 8.5 (3.7) 6.2 (3.3)
Values are mean (SD) and n (%). BHS = Bogalusa Heart Study; YFS = Cardiovascular Risk in Young Finns Study;
MUSC = Muscatine Study; NGHS = NHLBI Growth and Health Study; PHBPC = Prevention of High Blood
Pressure in Children; BMI = body mass index; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density
lipoprotein cholesterol; TG = triglycerides; AUCt = total area under the curve; AUCi = incremental area under the
curve. a Overweight was defined as BMI ≥25 kg/m2 and <30 kg/m2; b Obesity was defined as BMI ≥ 30 kg/m2.
Figure 1 presents longitudinal trajectories of BMI from childhood to adulthood by race and sex.
Black females had the fastest increase and highest levels from childhood to adulthood followed by
black males, white males and white females. The growth curve of BMI in black females was separated
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from other groups around 10 years and beyond. The other three groups had similar trajectories until
around 20 years of age; thereafter, white females tended to have a slower rate of increase and lower
levels. Curve parameters (β0 + b0, β1 + b1, β2 + b2 and β3 + b3) for BMI were all significantly different
from 0.
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Figure 1. Growth curves of body mass index (BMI) by race and sex.
Figure 2 presents growth curves of BMI from childhood to adulthood in participants with abnormal
versus normal lipid levels. Participants with dyslipidemia, high LDL-C, low HDL-C and high TG had
consistently higher BMI levels from childhood to adulthood compared to those with normal lipid levels.
The differences in BMI levels between the two comparison groups became greater with increasing age.
Growth curves of BMI in adult dyslipidemia groups by race and sex were presented in Supplemental
Figure S2.
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Figure 2. Gr th curves of BMI in groups classified by dyslipidemia groups. BMI = b dy mass
index; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density lipoprotein cholesterol;
TG = triglycerides.
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Table 2 presents detailed information on curve parameters in participants with abnormal versus
normal lipid levels. Adults with dyslipidemia compared to those with normal lipid levels had
significantly greater values of β0 + b0, β1 + b1 and β2 + b2, but lower β3+b3. Trends in the differences
were similar between abnormal and normal groups of LDL-C, HDL-C and TG, except for the difference
in β2 + b2 between low and normal HDL-C groups.
Table 2. Growth curve parameters of BMI in means (SDs) between dyslipidemia groups.
Curve Parameters Dyslipidemia High LDL-C Low HDL-C High TG
n (yes/no) 1916/3279 776/4419 1355/3840 719/4476
β0 + b0 (kg/m2)
Yes 25.3 (5.3) 24.9 (4.8) 26.0 (5.5) 25.4 (5.0)
No 23.5 (4.4) 24.1 (4.8) 23.6 (4.4) 24.0 (4.8)
P a <0.001 <0.001 <0.001 <0.001
β1 + b1 (kg/m2/year)
Yes 0.45 (0.26) 0.43 (0.24) 0.47 (0.27) 0.48 (0.24)
No 0.32 (0.26) 0.35 (0.27) 0.33 (0.26) 0.35 (0.27)
p a <0.001 <0.001 <0.001 <0.001
β2 + b2 (10 kg/m2/year2) b
Yes −0.101 (0.100) −0.091 (0.087) −0.108 (0.104) −0.093 (0.095)
No −0.106 (0.096) −0.107 (0.099) −0.103 (0.094) −0.106 (0.098)
p a 0.043 <0.001 0.155 <0.001
β3 + b3 (20 kg/m2/year3) b
Yes 0.002 (0.010) 0.002 (0.009) 0.002 (0.010) 0.001 (0.009)
No 0.005 (0.011) 0.004 (0.011) 0.004 (0.010) 0.004 (0.011)
p a <0.001 <0.001 <0.001 <0.001
BMI = body mass index; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density; lipoprotein cholesterol;
TG = triglycerides; Dyslipidemia was defined as any of high LDL-C, low HDL-C or high TG; a p-values for difference
in βs + bs between dyslipidemia and normal groups were adjusted for average age, race, sex and cohort, with
additional adjustment for β0 + b0 for other curve parameters; b β2 + b2 and β3 + b3 were estimated using the terms
of age2/10 and age3/20, respectively, for model fitting.
Table 3 presents the odds ratios (ORs) for adult dyslipidemia in association with BMI in terms of
childhood and adulthood, as well as total and incremental AUC values, adjusted for adult age, race,
sex and cohort in separate regression models. All BMI values were associated with increased risk
of adult dyslipidemia, high LDL-C, low HDL-C and high TG (p < 0.01 for all). Adult BMI had the
highest OR (95% confidence interval) of 1.85 (1.74–1.97) for adult dyslipidemia, which was significantly
greater than 1.22 (1.15–1.29), 1.61 (1.52–1.71) and 1.59 (1.50–1.69) for childhood BMI, total AUC and
incremental AUC, respectively. Most of the associations remained significant in stratified analyses
by race and sex (Supplemental Table S3). For white participants, females versus males had stronger
associations of childhood BMI with dyslipidemia, high LDL-C and low HDL-C, and total AUC with
low HDL-C, but a weaker association of adulthood BMI with high TG; no sex difference was found
for black participants. Race differences in ORs for dyslipidemia (whites > blacks) were significant
in females, with the exception of childhood BMI. Whites versus blacks had stronger associations of
adult BMI with high TG. The total AUC-low HDL-C association was stronger in whites than in blacks
in females.
Supplemental Table S4 shows the associations of BMI measures with dyslipidemia by adult age
groups. All the ORs were significant except for childhood BMI in the age groups of 36–40, 41–45 and
≥46 years. There were no significant differences in strengths of the associations measured as OR values
between adult age subgroups.
Supplemental Figure S3 shows ORs for lipid disorders according to childhood and adulthood
BMI status after adjusting for race, sex, age and cohort. Compared with individuals with normal BMI
consistently from childhood to adulthood (the low/low group), those in the high/high and low/high
groups had significantly higher risks of dyslipidemia, high LDL-C, low HDL-C and high TG in
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adulthood. In addition, individuals with high childhood BMI but normal adult BMI had similar ORs
for dyslipidemia, high LDL-C and low HDL-C and a lower OR for high TG.
Table 3. Standardized odds ratios (ORs) and 95% confidence intervals (CIs) of BMI measures for
adult dyslipidemia.
Independent Variable Dependent Variable
Dyslipidemia High LDL-C Low HDL-C High TG
Childhood BMI a 1.22 (1.15–1.29) 1.10 (1.02–1.19) 1.29 (1.22–1.37) 1.13 (1.05–1.22)
Adulthood BMI 1.85 (1.74–1.97) 1.42 (1.32–1.53) 1.82 (1.71–1.95) 1.65 (1.53–1.77)
BMI AUCt b 1.61 (1.52–1.71) 1.30 (1.21–1.40) 1.68 (1.57–1.79) 1.48 (1.38–1.59)
BMI AUCi c 1.59 (1.50–1.69) 1.30 (1.21–1.40) 1.62 (1.52–1.73) 1.50 (1.40–1.62)
ORs are all significantly greater than 1 (p < 0.01). BMI = body mass index; LDL-C = low-density lipoprotein
cholesterol; HDL-C = high-density lipoprotein cholesterol; TG = triglycerides; AUCt = total area under the curve;
AUCi = incremental area under the curve; Dyslipidemia was defined as any of high LDL-C, low HDL-C or high
TG. Covariates included adult age, race, sex and cohort. ORs of the four BMI measures were estimated in separate
models; a adjusted for childhood age prior to regression analyses; b adjusted for average age prior to regression
analyses; c adjusted for average age and childhood BMI prior to regression analyses.
Supplemental Table S5 shows ORs of BMI burden for adult dyslipidemia with and without
including the last adult BMI in the model. After adjusting for race, sex, age and cohort, BMI burden
from childhood was positively associated with increased risk of adult dyslipidemia in model 1s
(p < 0.05 for all). When BMI burden and the last adult BMI were both included in the model (model 3s),
the associations of BMI burden with dyslipidemia, high LDL-C, low HDL-C and high TG became
negative (ORs < 1, p < 0.05 for all), and the ORs of the last adult BMI were greater than 1 (p < 0.05 for
all).
4. Discussion
Using pooled data on repeated BMI measurements from childhood to midlife age from five
longitudinal cohorts in the i3C Consortium, we characterized nonlinear BMI growth trajectories from
childhood by race and sex. Adults with dyslipidemia had higher long-term BMI levels and greater
linear slopes and change in slopes compared to those with normal lipid levels. Childhood BMI,
adulthood BMI, long-term burden and increasing trends (AUCs) were positively and significantly
associated with increased risk of adult dyslipidemia. These findings suggest that the influence of high
BMI on the development of dyslipidemia begins at early life stages.
The strong relationship between obesity and adverse lipid profiles, including high LDL-C, low
HDL-C and high TG, in both youth and adults has been documented in numerous cross-sectional
studies [5,7]. Intervention studies have shown that weight loss through lifestyle changes has a
significant desirable effect on lipid levels [28,29]. Longitudinal studies have reported that increased
childhood BMI at a single time point is positively associated with cardiometabolic risk including lipid
disorders in later life [8–12]. A previous i3C Consortium analysis has demonstrated that increased
childhood BMI affects adult lipid profiles through adult obesity [30]. The influence of life-long
cumulative burden of excessive adiposity on the development of dyslipidemia has not been adequately
described. By taking advantage of multiple repeated measurements of BMI in longitudinal cohorts of
the i3C Consortium, we found that high values of childhood BMI and its long-term cumulative burden
measured as total AUC predicted increased risk of dyslipidemia in middle-aged adults. By comparing
the growth curves of BMI, the difference in BMI levels between the normal and abnormal lipids groups
became greater with increasing age, indicating that the effect of excessive body weight on dyslipidemia
is accumulative and exacerbated during a person’s lifetime. In addition, we found that the associations
of BMI with low HDL-C and high TG were stronger than the association for high HDL-C, which was
consistent with previous studies [31,32]. Studies have shown that obesity leads to lipid metabolism
abnormality, mainly due to free fatty acid release in excess of metabolic demand [31].
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During the last two decades, group-based trajectory modeling has been widely used to characterize
trajectory patterns of repeated measures of BMI over time. Several longitudinal studies that began
in early life have reported that BMI trajectories from childhood are associated with increased risk of
cardiovascular disease, type 2 diabetes, insulin resistance and cardiometabolic risk in adulthood [16–19].
In the Young Finns Study, six discrete groups of long-term BMI trajectories from childhood were
identified, and individuals who had a BMI at high levels, over time, had increased cardiometabolic risk
(hypertension, high LDL-C, low HDL-C and high TG) in midlife [16]. Group-based trajectory modeling
was developed to generate the group average of curve parameters and use group membership as a
predictor variable. In the current study, incremental AUC was calculated using the combination of
linear and nonlinear BMI growth curve parameters to measure the long-term trends for each individual.
We found a significant association of increasing trends in BMI measured as incremental AUC with
adult dyslipidemia.
The growth curve parameters estimated in the random-effects model in this study provided
detailed information on individual-specific parameters in specific age periods, as shown in Figure 1.
β0 + b0 is the intercept (the level of BMI at age of 22.1) because age was centered at its sample mean
value; β1 + b1 describes linear slopes (the tangent lines) at the age point of 22.1; the negativeβ2 + b2 from
3 to ~40 years shows that linear slopes at age points become smaller and smaller in this age period; and
β3 + b3 reflects that β2 + b2 changes from negative to positive at inflection points which vary between
37 and 52 years by race–sex groups. In this study, participants with dyslipidemia had higher long-term
levels and steeper rates of increase in BMI than those with normal lipids. The smaller absolute values
of the negative β2 + b2 in dyslipidemic adults indicated that the linear slopes of BMI at age points from
childhood in this group were greater than the normal lipid group. The lower values of β3 + b3 among
dyslipidemic adults, as shown in Table 2, might be affected by the regression-to-the-mean phenomenon.
BMI changes dramatically with age and has substantial within-person variation over time. The rate of
increase in BMI tended to slow down in dyslipidemic adults because they already had relatively higher
BMI levels before the onset of dyslipidemia. The major strength of our individual-specific parameter
analysis is to provide the potential for identification of sensitive age windows in BMI change for future
health outcomes.
Marked differences in long-term levels and trajectories of BMI and lipid levels in adults were noted
between race–sex groups in the present study cohort. The black–white differences in cardiovascular
risk factors are well documented in previous studies [33–35]. Of note, the race–sex differences in BMI
in black females even occurred in childhood. These race–sex differences in BMI in early life were also
seen in a study of 29,254 children [35]. Despite substantial black–white and sex differences in levels of
BMI and lipids, the strength of BMI–dyslipidemia associations did not differ significantly between
race–sex subgroups in most models, as shown in Supplemental Table S2. We, therefore, combined the
race–sex subgroups and reported the results of the total cohort.
Previous studies have reported that childhood BMI is significantly associated with adult
dyslipidemia; however, the association disappeared when taking adult BMI into account [11,30].
In line with previous findings [30], we noted that adult BMI had the strongest association with the
concurrent dyslipidemia, and the effect of childhood BMI was dependent on adult BMI. It is well-known
that childhood BMI is closely correlated with adult BMI, and early-life obesity tends to track or persist
to later life [13,14]. Existing evidence from this and previous studies suggests that the influence of
excessive body weight in early life on the development of lipid disorders is mainly mediated through
the strong tracking correlation of body weight during growth periods [30]. The additional information
provided in this study is that the long-term impact of excessive body weight on adult dyslipidemia is
amplified with increasing age from childhood.
The current longitudinal study cohorts from the i3C Consortium with large sample size and
repeated BMI measurements from childhood provided a unique opportunity to characterize the
life-course individual-level trajectories of BMI. This study also has certain limitations. First, although
BMI is widely used as a measure to diagnose obesity, it cannot discriminate fat mass and lean mass.
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Second, continuous lipid variables in adults were not analyzed due to lipid-lowering medications.
Third, adult BMI was included in the growth curve model fitting to calculate the life-time cumulative
burden of BMI. The stronger cross-sectional association at the last adult point raised the associations of
the long-term burden and trajectories of BMI with lipids.
In summary, the longitudinal cohorts of the i3C Consortium demonstrated that adults with
dyslipidemia had consistently higher levels and distinct life-course trajectories of BMI from childhood
to adulthood compared with those with normal lipids. Although it is still not possible to precisely
diagnose which children are at risk for adult dyslipidemia, elevated BMI and its increasing trends
are a life-long burden for adult dyslipidemia. Adults with dyslipidemia had higher long-term BMI
levels and greater linear slopes and change in slopes compared to those with normal lipids levels.
The consistent and strong associations of elevated BMI in early life and its longitudinal burden with
adult dyslipidemia observed in this study support the notion that dyslipidemia is the most common
comorbidity associated with obesity. The findings underscore the importance of life-long weight control,
beginning in childhood, in improving lipid profiles and thus reducing future cardiovascular risk.
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